O'Shaughnessy Asset Management, LLC Coherus Bio Sciences, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$15.81 - $18.99 $21,406 - $25,712	-1,354 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$12.95 - $15.41 $14,594 - $17,367	1,127 Added 496.48%	1,354 $19,000
Q2 2020 Aug 13, 2020	BUY	$14.43 - $19.16 $3,275 - $4,349	227 New	227 $4,000
Q1 2020 May 13, 2020	SELL	$11.67 - $22.53 $2,649 - $5,114	-227 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$16.33 - $21.37 $3,706 - $4,850	227 New	227 $4,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $99.5M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.